Document Detail


Microvascular function/dysfunction downstream a coronary stenosis.
MedLine Citation:
PMID:  23173585     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
For decades coronary macrovascular atherosclerosis has been considered the principal manifestation of coronary heart disease, with most of our effort dedicated to identifying and removal of coronary stenosis. However, growing body of literature indicates that coronary microcirculation also contributes substantially to the pathophysiology of cardiovascular disease. An understanding of mechanisms regulating microvascular function is of critical importance in understanding its role in disease, especially because these regulatory mechanisms vary substantially across species, vascular bed and due to comorbidities. Indeed, the most obvious consequence of coronary stenosis is that it may limit blood supply to the dependent myocardium to the point of causing ischaemia during exercise or even at rest. However, this flow limiting effect is not only due to the passive hydraulic effect of a narrowed conduit, but also to active responses in the coronary microcirculation triggered by the presence of an epicardial stenosis. To understand this problem it is important to review the inter-related mechanisms that regulate flow to the left ventricular wall and modulate transmural distribution of flow. These regulatory mechanisms operate hierarchically and are heterogeneously distributed along the coronary vascular tree. It is also important to discuss the effect of myocardial performance in modulating both blood flow demands and coronary resistance. Some of the interactions between coronary stenosis and microcirculation are transient, like those documented in acute coronary syndromes or during percutaneous interventions. However, microcirculatory remodeling may be triggered by a chronic coronary stenosis, leading to a sustained impairment of blood supply even after successful removal of the epicardial stenosis. A deeper understanding of these phenomena may explain paradoxical findings in patients undergoing coronary revascularization, particularly when functional tests are used in their assessment. These aspects are discussed in detail in this review.
Authors:
Giacinta Guarini; Paola Giuseppina Capozza; Alda Huqi; Doralisa Morrone; William M Chilian; Mario Marzilli
Related Documents :
12895455 - Neutrophils do not contribute to infarction, oxidative stress, and no synthase activity...
14575695 - Bcl-xl gene transfer protects the heart against ischemia/reperfusion injury.
15367825 - 3,4,5,6-tetrahydroxyxanthone protects against myocardial ischemia-reperfusion injury in...
24219045 - The clinical and economic impact of bivalirudin for percutaneous coronary intervention.
15367535 - Percutaneous device closure of a pseudoaneurysm of the left ventricular wall.
24796715 - Myocardial infarction and functional outcome assessment in pigs.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-19
Journal Detail:
Title:  Current pharmaceutical design     Volume:  -     ISSN:  1873-4286     ISO Abbreviation:  Curr. Pharm. Des.     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-23     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9602487     Medline TA:  Curr Pharm Des     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
Cardiovascular Medicine Division, Cardio Thoracic and Vascular Department, University of Pisa Via Paradisa 2, 56124 Pisa, Italy. mario.marzilli@med.unipi.it.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Effect of aging on metabolic pathways in endothelial progenitor cells.
Next Document:  Structural Alterations of the Retinal Microcirculation in the "Prehypertensive" High-Normal Blood Pr...